Cargando…
Decreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells
BACKGROUND: The vascular endothelial growth factor (VEGF)-VEGF receptor (VEGFR) signaling pathway is involved in cancer-related biological functions and is a therapeutic target in cancer. However, the influence of epigenetic regulation of VEGF-VEGFR signaling-related genes remains unclear. Here, we...
Autores principales: | Kim, Jee Yeon, Hwang, Junha, Lee, Seo Hyun, Lee, Hyo Jin, Jelinek, Jaroslav, Jeong, Hyeseon, Lim, Jae Sung, Kim, Jin Man, Song, Kyu Sang, Kim, Byung Hoon, Lee, Sukhoon, Kim, Jei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572656/ https://www.ncbi.nlm.nih.gov/pubmed/26380584 http://dx.doi.org/10.1186/s13148-015-0134-9 |
Ejemplares similares
-
Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis
por: Kim, Jee Yeon, et al.
Publicado: (2020) -
Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence
por: Jeong, Hye Seon, et al.
Publicado: (2017) -
Hypomethylation in MTNR1B: a novel epigenetic marker for atherosclerosis profiling using stenosis radiophenotype and blood inflammatory cells
por: Kim, Jee Yeon, et al.
Publicado: (2023) -
Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer
por: Lim, Byungho, et al.
Publicado: (2018) -
The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
por: Lim, Sung Hee, et al.
Publicado: (2016)